When faced with an infected ingrown hair, the first rule is to avoid puncturing the bump to drain the pus.
This manipulation, often performed with the fingers or a non-sterile object, facilitates the introduction of new bacteria into an already infected hair follicle. It can thus exacerbate local inflammation, prolong the infection’s duration, and increase the risk of complications, such as the formation of boils, which correspond to a deep infection of the pilosebaceous follicle.
Treatment relies primarily on appropriate hygiene measures. It is recommended to gently cleanse the affected area once or twice daily with lukewarm water and a mild cleanser to limit bacterial proliferation without further compromising the skin barrier. Daily application of a topical antiseptic may also be considered to reduce bacterial load.
In certain pronounced inflammatory cases, the healthcare provider may also recommend a topical corticosteroid cream for ingrown hairs to reduce inflammation and perifollicular edema. It is equally essential to suspend any form of hair removal or shaving on the affected area until the lesions have completely resolved, to avoid perpetuating the inflammation and the emergence of new follicular infections.
In most cases, the infection associated with an ingrown hair remains superficial and transient, with resolution in a few days. However, if lesions become very painful, spread, are accompanied by systemic signs, or progress to an abscess, a dermatology consultation is necessary. Depending on the severity, the physician may prescribe topical or oral antibiotics to control the bacterial infection. Other local approaches may also be proposed, such as benzoyl peroxide, which has antibacterial properties, or retinoids topical, which help normalize follicular keratinization and limit recurrences.
In certain cases, other therapeutic approaches may be considered. When infected ingrown hairs give rise to persistent pigmented spots, particularly in darker skin phototypes, the dermatologist may recommend the use of depigmenting agents such as hydroquinone. This compound works by inhibiting tyrosinase, a key enzyme in the melanin synthesis process, and allows for the gradual reduction of post-inflammatory hyperpigmentation.
In patients presenting with infected ingrown hairs that are frequent and resistant to conventional measures, particularly in the context of Pseudofolliculitis barbae, laser therapy represents a compelling long-term option. By targeting the hair follicle and reducing hair density and rigidity, the laser lowers the risk of subcutaneous regrowth and, consequently, the associated inflammatory and infectious phenomena.
Furthermore, especially in women, the use of topical eflornithine can also be recommended. This molecule inhibits ornithine decarboxylase, an enzyme involved in hair growth, thereby slowing hair regrowth. By reducing the frequency of shaving or hair removal, it indirectly helps limit ingrown hairs and associated follicular infections.
Finally, when infected ingrown hairs occur in the context of excessive or atypical hair growth, an endocrinological evaluation may be appropriate. A hormonal imbalance, notably hyperandrogenism, can promote dense, coarse hair, mechanically increasing the risk of ingrown hairs and chronic folliculitis.